1. Home
  2. WTO vs PULM Comparison

WTO vs PULM Comparison

Compare WTO & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WTO

UTime Limited

N/A

Current Price

$1.08

Market Cap

5.1M

Sector

Technology

ML Signal

N/A

PULM

Pulmatrix Inc.

N/A

Current Price

$1.32

Market Cap

4.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WTO
PULM
Founded
2008
2003
Country
China
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.9M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
WTO
PULM
Price
$1.08
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
207.9K
15.0K
Earning Date
03-18-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
46.18
EPS
N/A
N/A
Revenue
N/A
$7,910,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5069.93
52 Week Low
$0.02
$1.16
52 Week High
$4.50
$9.22

Technical Indicators

Market Signals
Indicator
WTO
PULM
Relative Strength Index (RSI) 40.80 49.22
Support Level $1.02 $1.21
Resistance Level $1.21 $1.44
Average True Range (ATR) 0.21 0.08
MACD 0.06 0.01
Stochastic Oscillator 31.37 52.17

Price Performance

Historical Comparison
WTO
PULM

About WTO UTime Limited

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: